Andere Sprachen Guangxi Wuzhou Zhongheng Group Co.,Ltd

Aktien

A0M4EC

CNE0000015F9

600252

Schlusskurs Shanghai S.E. Andere Börsenplätze 00:00:00 21.05.2024			% 5 Tage	% 1. Jan.
2,43 ^CNY	-1,22 %		-0,82 %	-3,19 %

29.04.	Guangxi Wuzhou Zhongheng Group Co.,Ltd meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI
17.04.	Guangxi Wuzhou Zhongheng Group Co.,Ltd (SHSE:600252) beginnt im Rahmen der am 28. März 2024 erteilten Genehmigung mit dem Rückkauf von Aktien im Wert von 200 Millionen CNY.	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	29.04.
Guangxi Wuzhou Zhongheng Group Co.,Ltd commences an Equity Buyback for CNY 200 million worth of its shares, under the authorization approved on March 28, 2024.	17.04.
Guangxi Honggui Capital Operation Group Co.,Ltd. agreed to acquire 18% stake in Guangxi United Asset Management Co., Ltd from Guangxi Wuzhou Zhongheng Group Co.,Ltd for approximately CNY 190 million.	09.04.
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	29.03.
Lummy Pharma Gets Nod to Raise Dosage of Gastric Drug	18.03.
Wuzhou Zhongheng’s Drug For Preventing Chemotherapy-Related Nausea Passes Consistency Test	10.11.
Sealand Securities Co., Ltd. announced that it has received CNY 3.192189985 billion in funding from a group of investors	10.11.
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27.10.23
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) added to S&P Global BMI Index	18.09.23
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) added to FTSE All-World Index	18.09.23
Wuzhou Zhongheng Gets Nod to Trial Ovarian Cancer Drug	15.09.23
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	29.08.23
Guangxi Wuzhou Zhongheng Receives 42 Million Yuan in Government Subsidy	17.08.23
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	27.04.23
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	28.03.23
Restrictions on Guangxi Wuzhou Zhongheng Drugs in 2022 Chinese Drug Catalogue Amended	24.01.23
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	28.10.22
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	26.08.22
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) dropped from S&P Global BMI Index	20.06.22
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) dropped from FTSE All-World Index	13.06.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Guangxi Wuzhou Zhongheng Group Co.,Ltd

Aktien

A0M4EC

CNE0000015F9

600252

Andere Sprachen

Filter